High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

被引：0
作者：
Galligioni, E [1 ]
Cetto, G [1 ]
Nascimben, O [1 ]
Buonadaona, A [1 ]
Crivellari, D [1 ]
Molino, A [1 ]
Veronesi, A [1 ]
Graiff, C [1 ]
Barni, S [1 ]
Puccetti, C [1 ]
Ferrazzi, E [1 ]
Recaldin, E [1 ]
Sava, C [1 ]
Saracchini, S [1 ]
Sacco, C [1 ]
机构：
[1] Ctr Riferimento Oncol, GOCCNE, I-33081 Aviano, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89301-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P84
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
    Zhang, Minmin
    Wei, Wei
    Liu, Jianlun
    Yang, Huawei
    Jiang, Yi
    Tang, Wei
    Li, Qiuyun
    Liao, Xiaoming
    ONCOTARGETS AND THERAPY, 2016, 9 : 3443 - 3450
  • [42] Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer
    Colleoni, M
    Price, K
    Castiglione-Gertsch, M
    Goldhirsch, A
    Coates, A
    Lindtner, J
    Collins, J
    Gelber, RD
    Thürlimann, B
    Rudenstam, CM
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (11) : 1693 - 1700
  • [43] THE EFFECT OF POSTOPERATIVE AND PRIMARY RADIATION-THERAPY ON DELIVERED DOSE OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL (CMF) CHEMOTHERAPY IN BREAST-CANCER
    LEVINE, JF
    COLEMAN, CN
    COX, RS
    RAY, GR
    ROGOWAY, WM
    MARTINEZ, A
    STOCKDALE, FE
    CANCER, 1984, 53 (02) : 237 - 241
  • [44] Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer
    Piccart, MJ
    Di Leo, A
    Beauduin, M
    Vindevoghel, A
    Michel, J
    Focan, C
    Tagnon, A
    Ries, F
    Gobert, P
    Finet, C
    Closon-Dejardin, MT
    Dufrane, JP
    Kerger, J
    Liebens, F
    Beauvois, S
    Bartholomeus, S
    Dolci, S
    Lobelle, JP
    Paesmans, M
    Nogaret, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3103 - 3110
  • [45] High dose epirubicin and cyclophosphamide in breast cancer stage IIIB
    Sarmiento U.B.
    Morales J.A.
    Bujanda D.A.
    Hidalgo A.C.
    Revista de Oncología, 2004, 6 (6): : 347 - 352
  • [46] Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer
    Amadori, Dino
    Silvestrini, Rosella
    De Lena, Mario
    Boccardo, Francesco
    Rocca, Andrea
    Scarpi, Emanuela
    Schittulli, Francesco
    Brandi, Mario
    Maltoni, Roberta
    Serra, Patrizia
    Ponzone, Riccardo
    Biglia, Nicoletta
    Gianni, Lorenzo
    Tienghi, Amelia
    Valerio, Maria Rosaria
    Bonginelli, Paola
    Amaducci, Laura
    Faedi, Marina
    Baldini, Editta
    Paradiso, Angelo
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 775 - 784
  • [47] Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: A randomized study in premenopausal breast cancer patients
    Saarto, T
    Blomqvist, C
    Valimaki, M
    Makela, P
    Sarna, S
    Elomaa, I
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1341 - 1347
  • [48] LOW-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, 5-FLUOROURACIL (CAMF) VERSUS SEQUENTIAL CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) AND ADRIAMYCIN
    CREECH, RH
    CATALANO, RB
    HARRIS, DT
    ENGSTROM, PF
    GROTZINGER, PJ
    CANCER, 1979, 43 (01) : 51 - 59
  • [49] Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
    Sun, Weiling
    Li, Chunhong
    Liu, Meiyan
    Liu, Wei
    Yang, Chunyu
    Cai, Li
    ONCOLOGY LETTERS, 2016, 11 (03) : 2320 - 2326
  • [50] Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer
    Baldini, E
    Gardin, G
    Giannessi, PG
    Evangelista, G
    Roncella, M
    Prochilo, T
    Collecchi, P
    Rosso, R
    Lionetto, R
    Bruzzi, P
    Mosca, F
    Conte, PF
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 227 - 232
12345